Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 1 to 9 of 9 entries
Sorted by: Best Match Show Resources per page
Prevalence and Resolution of Lupus Anticoagulant in Children.

The Ochsner journal

Kallanagowdar C, Chauhan A, Puertolas MV, Warrier R.
PMID: 27303229
Ochsner J. 2016;16(2):172-5.

BACKGROUND: Lupus anticoagulant (LA) is an autoantibody that inhibits phospholipid-dependent reactions. Studies on the incidence and prevalence of LA in the pediatric population are lacking. The objective of our study was to determine the incidence and potential risk of...

Cite
Kallanagowdar C, Chauhan A, Puertolas MV, et al. Prevalence and Resolution of Lupus Anticoagulant in Children. Ochsner J. 2016;16(2):172-5
Kallanagowdar, C., Chauhan, A., Puertolas, M. V., & Warrier, R. (2016). Prevalence and Resolution of Lupus Anticoagulant in Children. The Ochsner journal, 16(2), 172-5.
Kallanagowdar, Chandra, et al. "Prevalence and Resolution of Lupus Anticoagulant in Children." The Ochsner journal vol. 16,2 (2016): 172-5.
Kallanagowdar C, Chauhan A, Puertolas MV, Warrier R. Prevalence and Resolution of Lupus Anticoagulant in Children. Ochsner J. 2016;16(2):172-5. PMID: 27303229; PMCID: PMC4896663.
Copy Download .nbib Format: NLM
Carotid free-floating thrombus causing stroke in a young woman with lupus anticoagulant: A case report and review of the literature.

International journal of surgery case reports

Afsharfard A, Gholizadeh B, Abdolalian Y, Hosseini SM.
PMID: 28267664
Int J Surg Case Rep. 2017;33:35-37. doi: 10.1016/j.ijscr.2017.01.067. Epub 2017 Feb 20.

INTRODUCTION: In young adults Stroke is a challenging condition and various tests are needed to diagnose and manage its underlying problems. Free floating thrombosis of internal carotid artery (FFT-ICA) is one of the rare problems among carotid artery diseases...

Cite
Afsharfard A, Gholizadeh B, Abdolalian Y, et al. Carotid free-floating thrombus causing stroke in a young woman with lupus anticoagulant: A case report and review of the literature. Int J Surg Case Rep. 2017;33:35-37doi: 10.1016/j.ijscr.2017.01.067.
Afsharfard, A., Gholizadeh, B., Abdolalian, Y., & Hosseini, S. M. (2017). Carotid free-floating thrombus causing stroke in a young woman with lupus anticoagulant: A case report and review of the literature. International journal of surgery case reports, 3335-37. https://doi.org/10.1016/j.ijscr.2017.01.067
Afsharfard, Abolfazl, et al. "Carotid free-floating thrombus causing stroke in a young woman with lupus anticoagulant: A case report and review of the literature." International journal of surgery case reports vol. 33 (2017): 35-37. doi: https://doi.org/10.1016/j.ijscr.2017.01.067
Afsharfard A, Gholizadeh B, Abdolalian Y, Hosseini SM. Carotid free-floating thrombus causing stroke in a young woman with lupus anticoagulant: A case report and review of the literature. Int J Surg Case Rep. 2017;33:35-37. doi: 10.1016/j.ijscr.2017.01.067. Epub 2017 Feb 20. PMID: 28267664; PMCID: PMC5338895.
Copy Download .nbib Format: NLM
The effect of unfractionated heparin, enoxaparin, and danaparoid on lupus anticoagulant testing: Can activated carbon eliminate false-positive results?.

Research and practice in thrombosis and haemostasis

De Kesel PMM, Devreese KMJ.
PMID: 31989098
Res Pract Thromb Haemost. 2019 Dec 10;4(1):161-168. doi: 10.1002/rth2.12264. eCollection 2020 Jan.

BACKGROUND: Heparins and heparinoids interfere with functional clotting assays used for lupus anticoagulant (LAC) detection. However, current guidelines for LAC testing do not provide clear guidance on this matter.OBJECTIVES: We aimed to assess to effect of unfractionated heparin (UFH),...

Cite
De Kesel PMM, Devreese KMJ. The effect of unfractionated heparin, enoxaparin, and danaparoid on lupus anticoagulant testing: Can activated carbon eliminate false-positive results?. Res Pract Thromb Haemost. 2019;4(1):161-168doi: 10.1002/rth2.12264.
De Kesel, P. M. M., & Devreese, K. M. J. (2020). The effect of unfractionated heparin, enoxaparin, and danaparoid on lupus anticoagulant testing: Can activated carbon eliminate false-positive results?. Research and practice in thrombosis and haemostasis, 4(1), 161-168. https://doi.org/10.1002/rth2.12264
De Kesel, Pieter M M, and Devreese, Katrien M J. "The effect of unfractionated heparin, enoxaparin, and danaparoid on lupus anticoagulant testing: Can activated carbon eliminate false-positive results?." Research and practice in thrombosis and haemostasis vol. 4,1 (2020): 161-168. doi: https://doi.org/10.1002/rth2.12264
De Kesel PMM, Devreese KMJ. The effect of unfractionated heparin, enoxaparin, and danaparoid on lupus anticoagulant testing: Can activated carbon eliminate false-positive results?. Res Pract Thromb Haemost. 2019 Dec 10;4(1):161-168. doi: 10.1002/rth2.12264. eCollection 2020 Jan. PMID: 31989098; PMCID: PMC6971310.
Copy Download .nbib Format: NLM
Concomitant factor VIII inhibitor and lupus anticoagulant in an asymptomatic patient.

Journal of thrombosis and thrombolysis

Jacobs JW, Gisriel SD, Iyer K, Rinder HM.
PMID: 34697688
J Thromb Thrombolysis. 2021 Oct 25; doi: 10.1007/s11239-021-02591-4. Epub 2021 Oct 25.

Acquired hemophilia A, caused by autoantibodies that bind to and neutralize the activity of coagulation factor VIII (FVIII), almost universally presents as a severe bleeding diathesis. Lupus anticoagulants (LAs), autoantibodies directed against phospholipids or protein-phospholipid complexes, manifest clinically with...

Cite
Jacobs JW, Gisriel SD, Iyer K, et al. Concomitant factor VIII inhibitor and lupus anticoagulant in an asymptomatic patient. J Thromb Thrombolysis. 2021;doi: 10.1007/s11239-021-02591-4.
Jacobs, J. W., Gisriel, S. D., Iyer, K., & Rinder, H. M. (2021). Concomitant factor VIII inhibitor and lupus anticoagulant in an asymptomatic patient. Journal of thrombosis and thrombolysis, . https://doi.org/10.1007/s11239-021-02591-4
Jacobs, Jeremy W, et al. "Concomitant factor VIII inhibitor and lupus anticoagulant in an asymptomatic patient." Journal of thrombosis and thrombolysis vol. (2021). doi: https://doi.org/10.1007/s11239-021-02591-4
Jacobs JW, Gisriel SD, Iyer K, Rinder HM. Concomitant factor VIII inhibitor and lupus anticoagulant in an asymptomatic patient. J Thromb Thrombolysis. 2021 Oct 25; doi: 10.1007/s11239-021-02591-4. Epub 2021 Oct 25. PMID: 34697688; PMCID: PMC8544916.
Copy Download .nbib Format: NLM
Hematuria as the first sign of multiple myeloma.

Clinical case reports

Alves M, Moreno R, Rodrigues F, Rodrigues A, Fonseca T.
PMID: 28781859
Clin Case Rep. 2017 Jul 10;5(8):1358-1361. doi: 10.1002/ccr3.1062. eCollection 2017 Aug.

Patients with multiple myeloma may present with several signs and symptoms, inclusive of hemorrhagic diathesis. This case emphasizes the need to suspect uncommon etiologies for common signs and to be aware of the atypical effects of paraproteinemia.

Cite
Alves M, Moreno R, Rodrigues F, et al. Hematuria as the first sign of multiple myeloma. Clin Case Rep. 2017;5(8):1358-1361doi: 10.1002/ccr3.1062.
Alves, M., Moreno, R., Rodrigues, F., Rodrigues, A., & Fonseca, T. (2017). Hematuria as the first sign of multiple myeloma. Clinical case reports, 5(8), 1358-1361. https://doi.org/10.1002/ccr3.1062
Alves, Mariana, et al. "Hematuria as the first sign of multiple myeloma." Clinical case reports vol. 5,8 (2017): 1358-1361. doi: https://doi.org/10.1002/ccr3.1062
Alves M, Moreno R, Rodrigues F, Rodrigues A, Fonseca T. Hematuria as the first sign of multiple myeloma. Clin Case Rep. 2017 Jul 10;5(8):1358-1361. doi: 10.1002/ccr3.1062. eCollection 2017 Aug. PMID: 28781859; PMCID: PMC5538104.
Copy Download .nbib Format: NLM
Prothrombin Is Responsible for the Lupus Cofactor Phenomenon in a Patient with Lupus Anticoagulant/Hypoprothrombinemia Syndrome.

TH open : companion journal to thrombosis and haemostasis

Pengo V, Zardo L, Cattini MG, Bison E, Pontara E, Altinier S, Cheng C, Denas G.
PMID: 32159072
TH Open. 2020 Mar 09;4(1):e40-e44. doi: 10.1055/s-0040-1705091. eCollection 2020 Jan.

Lupus anticoagulant is a misnomer as it is commonly associated with thromboembolic events. In few cases, the name retains its literal meaning when it characterizes patients with a bleeding disorder. We describe a patient with lupus anticoagulant, hypoprothrombinemia, and...

Cite
Pengo V, Zardo L, Cattini MG, et al. Prothrombin Is Responsible for the Lupus Cofactor Phenomenon in a Patient with Lupus Anticoagulant/Hypoprothrombinemia Syndrome. TH Open. 2020;4(1):e40-e44doi: 10.1055/s-0040-1705091.
Pengo, V., Zardo, L., Cattini, M. G., Bison, E., Pontara, E., Altinier, S., Cheng, C., & Denas, G. (2020). Prothrombin Is Responsible for the Lupus Cofactor Phenomenon in a Patient with Lupus Anticoagulant/Hypoprothrombinemia Syndrome. TH open : companion journal to thrombosis and haemostasis, 4(1), e40-e44. https://doi.org/10.1055/s-0040-1705091
Pengo, Vittorio, et al. "Prothrombin Is Responsible for the Lupus Cofactor Phenomenon in a Patient with Lupus Anticoagulant/Hypoprothrombinemia Syndrome." TH open : companion journal to thrombosis and haemostasis vol. 4,1 (2020): e40-e44. doi: https://doi.org/10.1055/s-0040-1705091
Pengo V, Zardo L, Cattini MG, Bison E, Pontara E, Altinier S, Cheng C, Denas G. Prothrombin Is Responsible for the Lupus Cofactor Phenomenon in a Patient with Lupus Anticoagulant/Hypoprothrombinemia Syndrome. TH Open. 2020 Mar 09;4(1):e40-e44. doi: 10.1055/s-0040-1705091. eCollection 2020 Jan. PMID: 32159072; PMCID: PMC7062548.
Copy Download .nbib Format: NLM
A Study of Anti Beta-2 Glycoprotein I and Anti-Prothrombin Antibodies in Patients with Unexplained Recurrent Pregnancy Losses.

Indian journal of hematology & blood transfusion : an official journal of Indian Society of Hematology and Blood Transfusion

Singh A, Nangia A, Sharma S, Puri M.
PMID: 27065583
Indian J Hematol Blood Transfus. 2016 Jun;32(2):198-201. doi: 10.1007/s12288-015-0535-0. Epub 2015 Apr 03.

To compare the levels of IgG and IgM anti beta-2 glycoprotein I antibodies and IgG and IgM anti prothrombin antibodies among women with unexplained recurrent pregnancy losses and women with at least 2 live issues. To compare the prevalence...

Cite
Singh A, Nangia A, Sharma S, et al. A Study of Anti Beta-2 Glycoprotein I and Anti-Prothrombin Antibodies in Patients with Unexplained Recurrent Pregnancy Losses. Indian J Hematol Blood Transfus. 2015;32(2):198-201doi: 10.1007/s12288-015-0535-0.
Singh, A., Nangia, A., Sharma, S., & Puri, M. (2016). A Study of Anti Beta-2 Glycoprotein I and Anti-Prothrombin Antibodies in Patients with Unexplained Recurrent Pregnancy Losses. Indian journal of hematology & blood transfusion : an official journal of Indian Society of Hematology and Blood Transfusion, 32(2), 198-201. https://doi.org/10.1007/s12288-015-0535-0
Singh, Angad, et al. "A Study of Anti Beta-2 Glycoprotein I and Anti-Prothrombin Antibodies in Patients with Unexplained Recurrent Pregnancy Losses." Indian journal of hematology & blood transfusion : an official journal of Indian Society of Hematology and Blood Transfusion vol. 32,2 (2016): 198-201. doi: https://doi.org/10.1007/s12288-015-0535-0
Singh A, Nangia A, Sharma S, Puri M. A Study of Anti Beta-2 Glycoprotein I and Anti-Prothrombin Antibodies in Patients with Unexplained Recurrent Pregnancy Losses. Indian J Hematol Blood Transfus. 2016 Jun;32(2):198-201. doi: 10.1007/s12288-015-0535-0. Epub 2015 Apr 03. PMID: 27065583; PMCID: PMC4789006.
Copy Download .nbib Format: NLM
Characterization of antiphospholipid antibodies in chronic hepatitis B infection.

The Korean journal of hematology

Huh JY, Yi DY, Hwang SG, Choi JJ, Kang MS.
PMID: 21461302
Korean J Hematol. 2011 Mar;46(1):36-40. doi: 10.5045/kjh.2011.46.1.36. Epub 2011 Mar 15.

BACKGROUND: Many infections are associated with antiphospholipid antibodies (aPLs). The purpose of this study was to investigate the prevalence, persistence, clinical significance, and characteristics of aPLs in hepatitis B virus (HBV)-infected patients.METHODS: This study included 143 patients with HBV...

Cite
Huh JY, Yi DY, Hwang SG, et al. Characterization of antiphospholipid antibodies in chronic hepatitis B infection. Korean J Hematol. 2011;46(1):36-40doi: 10.5045/kjh.2011.46.1.36.
Huh, J. Y., Yi, D. Y., Hwang, S. G., Choi, J. J., & Kang, M. S. (2011). Characterization of antiphospholipid antibodies in chronic hepatitis B infection. The Korean journal of hematology, 46(1), 36-40. https://doi.org/10.5045/kjh.2011.46.1.36
Huh, Ji Young, et al. "Characterization of antiphospholipid antibodies in chronic hepatitis B infection." The Korean journal of hematology vol. 46,1 (2011): 36-40. doi: https://doi.org/10.5045/kjh.2011.46.1.36
Huh JY, Yi DY, Hwang SG, Choi JJ, Kang MS. Characterization of antiphospholipid antibodies in chronic hepatitis B infection. Korean J Hematol. 2011 Mar;46(1):36-40. doi: 10.5045/kjh.2011.46.1.36. Epub 2011 Mar 15. PMID: 21461302; PMCID: PMC3065625.
Copy Download .nbib Format: NLM
DOAC-Stop in lupus anticoagulant testing: Direct oral anticoagulant interference removed in most samples.

Research and practice in thrombosis and haemostasis

Baker SA, Jin J, Pfaffroth C, Vu T, Zehnder JL.
PMID: 33733031
Res Pract Thromb Haemost. 2021 Jan 27;5(2):314-325. doi: 10.1002/rth2.12472. eCollection 2021 Feb.

BACKGROUND: The use of direct oral anticoagulants (DOACs) is a convenient therapeutic option for patients at risk of thrombosis. DOACs interfere with clot-based testing for the identification of lupus anticoagulant antibodies (LACs) in patients with antiphospholipid syndrome (APS), a...

Cite
Baker SA, Jin J, Pfaffroth C, et al. DOAC-Stop in lupus anticoagulant testing: Direct oral anticoagulant interference removed in most samples. Res Pract Thromb Haemost. 2021;5(2):314-325doi: 10.1002/rth2.12472.
Baker, S. A., Jin, J., Pfaffroth, C., Vu, T., & Zehnder, J. L. (2021). DOAC-Stop in lupus anticoagulant testing: Direct oral anticoagulant interference removed in most samples. Research and practice in thrombosis and haemostasis, 5(2), 314-325. https://doi.org/10.1002/rth2.12472
Baker, Steven Andrew, et al. "DOAC-Stop in lupus anticoagulant testing: Direct oral anticoagulant interference removed in most samples." Research and practice in thrombosis and haemostasis vol. 5,2 (2021): 314-325. doi: https://doi.org/10.1002/rth2.12472
Baker SA, Jin J, Pfaffroth C, Vu T, Zehnder JL. DOAC-Stop in lupus anticoagulant testing: Direct oral anticoagulant interference removed in most samples. Res Pract Thromb Haemost. 2021 Jan 27;5(2):314-325. doi: 10.1002/rth2.12472. eCollection 2021 Feb. PMID: 33733031; PMCID: PMC7938630.
Copy Download .nbib Format: NLM
Showing 1 to 9 of 9 entries